Top Consideration For Onshoring Pharmaceutical Manufacturing: Find The Right CMO
Source: AbbVie

The Covid-19 pandemic pulled the curtain back and showed the American people the pharmaceutical supply chain's vulnerabilities, highlighting the U.S' dependency on China and other countries. Over the last few decades, drug manufacturers have been gradually moving production offshore, but policymakers and others are examining the need to bring manufacturing back to the U.S. When drug and API manufacturers decide to make the onshoring shift, they should be prepared with a well-designed quality system and a thorough tech transfer process. Partnering with the right CMO will ensure a smoother transfer.
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
AbbVie
This website uses cookies to ensure you get the best experience on our website. Learn more